CDC Panel Issues Broad Approval To New Boosters

NPR reports:

A panel of advisers to the Centers for Disease Control and Prevention backed the broad use of new COVID-19 vaccines, as cases of the respiratory illness rise.

The advisers voted 13-1 to recommend the vaccines for people ages 6 months and older. While the benefits appear to be greatest for the oldest and youngest people, the benefits of vaccination exceed the risks for everyone, according to a CDC analysis.

The last step before vaccination with the new shots can start is a formal decision by the CDC director. The decision is expected to quickly follow the panel’s vote. The new shots could become available as soon as Wednesday in some parts of the country.

Read the full article. FDA approval came yesterday.